Related references
Note: Only part of the references are listed.Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors
Gleice K. Silva-Cardoso et al.
NEUROPHARMACOLOGY (2021)
Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats
Priscila Vazquez-Leon et al.
NEUROSCIENCE LETTERS (2021)
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
Claire Alexander et al.
IBRO NEUROSCIENCE REPORTS (2021)
Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors
R. B. Malvestio et al.
BRAIN RESEARCH BULLETIN (2021)
CB1 and CB2 receptors in the bed nucleus of the stria terminalis differently modulate anxiety-like behaviors in rats
Lucas Gomes-de-Souza et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
Ani Gasparyan et al.
FRONTIERS IN PHARMACOLOGY (2021)
Gender differences in the effects of cannabidiol on ethanol binge drinking in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2020)
Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans
Verity L. Chadwick et al.
CURRENT OPINION IN PSYCHIATRY (2020)
Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
Neda Assareh et al.
BEHAVIOURAL PHARMACOLOGY (2020)
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete et al.
FRONTIERS IN PSYCHIATRY (2020)
Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear
Devon Ivy et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Maria S. Garcia-Gutierrez et al.
BIOMOLECULES (2020)
Integrating endocannabinoid signaling in the regulation of anxiety and depression
An-qi Yin et al.
ACTA PHARMACOLOGICA SINICA (2019)
Cannabidiol does not display drug abuse potential in mice behavior
Adrian Viudez-Martinez et al.
ACTA PHARMACOLOGICA SINICA (2019)
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Amanda J. Sales et al.
MOLECULAR NEUROBIOLOGY (2019)
Effects of cannabidiol in males and females in two different rat models of depression
Liat Shbiro et al.
PHYSIOLOGY & BEHAVIOR (2019)
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaca et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman et al.
NEURON (2019)
New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis
Fiona Charlson et al.
LANCET (2019)
Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism
Jerzy Zieba et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors
Alice Hartmann et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys
S. Evans-Lacko et al.
PSYCHOLOGICAL MEDICINE (2018)
Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal
Francisco Navarrete et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2018)
Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
Maria S. Garcia-Gutierrez et al.
NEUROTHERAPEUTICS (2018)
CHALLENGES OF TREATMENT-RESISTANT DEPRESSION
James Paul Pandarakalam
PSYCHIATRIA DANUBINA (2018)
WHO World Mental Health Surveys International College Student Project: Prevalence and Distribution of Mental Disorders
Randy P. Auerbach et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2018)
Cannabidiol reduces ethanol consumption, motivation and relapse in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2018)
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity
Katrina Hurst et al.
HIPPOCAMPUS (2017)
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors
T. Bakas et al.
PHARMACOLOGICAL RESEARCH (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress
Qi-xin Shi et al.
MOLECULAR BRAIN (2017)
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors
A. G. Sartim et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Assessing the Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression
Bradley Gaynes
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Endocannabinoid system: Role in depression, reward and pain control (Review)
Wen-Juan Huang et al.
MOLECULAR MEDICINE REPORTS (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Prohedonic Effect of Cannabidiol in a Rat Model of Depression
Gal Shoval et al.
NEUROPSYCHOBIOLOGY (2016)
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
Angelica Pupin Schiavon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
A. L. Z. Marinho et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats
Abbasali Rahimi et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Regulatory role of the cannabinoid CB2 receptor in stress- induced neuroinflammation in mice
S. Zoppi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
M. V. Fogaca et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
Aurelijus Burokas et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors
Fabricio H. Do Monte et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors
Maria S. Garcia-Gutierrez et al.
NEUROPHARMACOLOGY (2013)
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
Sofia Sisay et al.
PLOS ONE (2013)
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
Valeria Almeida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
Maria S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice
Francisco Navarrete et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
Alline Cristina Campos et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo
Wolfgang Jacob et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Antidepressant-like properties of α2-containing GABAA receptors
Isabel Vollenweider et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Decreased GABA(A) and GABA(B) receptor functional activity in cannabinoid CB1 receptor knockout mice
Leyre Urigueen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
Felipe V. Gomes et al.
PSYCHOPHARMACOLOGY (2011)
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
Eva M. Marco et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors
Plinio C. Casarotto et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
M. S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats
Grazyna Biala et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
Andrew P. Ray et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal
Alexandre Surget et al.
BIOLOGICAL PSYCHIATRY (2008)
Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: The GADIS II study (Generalized Anxiety and Depression Impact Survey II)
Marc Ansseau et al.
DEPRESSION AND ANXIETY (2008)
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
Fabricio A. Moreira et al.
NEUROPHARMACOLOGY (2008)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
Philip S. Wang et al.
LANCET (2007)
GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states
John C. Earnheart et al.
JOURNAL OF NEUROSCIENCE (2007)
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Fabricio A. Moreira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
M Kathmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
L Urigüen et al.
NEUROPHARMACOLOGY (2004)
Diagnosis and definition of treatment-resistant depression
M Fava
BIOLOGICAL PSYCHIATRY (2003)
Anandamide hydrolysis: a new target for anti-anxiety drugs?
S Gaetani et al.
TRENDS IN MOLECULAR MEDICINE (2003)
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviour
M Martin et al.
PSYCHOPHARMACOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
